Nosocomial Infection

FDA Advisory Committee Recommends Approval of Zyvox

Published in Medical Letter on the CDC and FDA, April 11th, 2000

The U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee has recommended approval of Zyvox (linezolid injection, tablets, and oral suspension Pharmacia & Upjohn) for the treatment of patients with hospital-acquired pneumonia.

The pneumonia also includes those cases caused by methicillin-resistant Staphylococcus aureus (MRSA); community-acquired pneumonia; and complicated and uncomplicated skin and skin structure infections, including cases with concurrent bacteremia (bloodstream infections).

The Committee also recommended approval of Zyvox for the treatment of infections caused by vancomycin-resistant...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-04-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry